The MYCN 5′ UTR as a therapeutic target in neuroblastoma
Marina P. Volegova(Harvard University), Rani E. George(Dana-Farber/Boston Children's Cancer and Blood Disorders Center)
Cited by 5
Related Papers
BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells
|Nature|2019|142
Cell lineage as a predictor of immune response in neuroblastoma
|bioRxiv (Cold Spring Harbor Laboratory)|2021|8